Sri Trang will ramp up capacity to 50 billion gloves next year and to 100 billion in 2026. It currently has a 32 billion-glove capacity.
I think it will play to its strength in latex & not be constrained by nitrile availability.
https://asia.nikkei.com/Business/Health-Care/Thai-medical-glove-maker-invests-1.6bn-to-triple-capacity-by-2026

For Supermax result, what I find most interesting is that in spite of higher revenue, Operating Expenses dropped quite a bit, so that's why profit margin is so good. Q1 is 313M vs 418M in Q4. That's a 24% drop. What could account for that? I thought they increased capacity & cost of raw material is going up. I looked at Top Glove for comparison & it's operating expenses went up qoq.

CIMB report
https://messenger.i3investor.com/res/msg/file/27922/2020/10/24dcd97f_3f31_419c_9522_afb0a68e9c16_1dsedsexdj20201021_20201021093603.pdf

This will give us an estimate of the fair mkt price based on the historical Fwd PE of 29x the annualised EPS at result announcement.

https://klse.i3investor.com/blogs/glovesvsvaccine/2020-09-04-story-h1513318067-Gloves_Top_Glove_Supermax_Harta_Kossan_it_s_all_about_PAT.jsp

Excellent piece of analysis. Thank you for sharing. Very exciting times indeed!

Hi OTB, thank you for sharing. Can I check how to get the latest analyst briefing that you have dated 11th Aug? I saw a copy that is dated 9th Aug, and I can not find the 3.3B cap increase you mentioned. On my copy, I see this on slide 16.
PLANT #12
Block A - fully operational
 Capacity - 2.2 billion per annum
Block B
 Installation of production lines resumed since 4.5.2020
 Target to start commissioning for 1
st 4 double former lines by 3Q CY2020
 Remaining 4 double formers lines by 4Q CY2020
 Capacity – 2.2 billion per annum

Thanks.